CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium
The two keynote speakers,
In addition, an abstract titled “Donor-derived cell-free DNA in renal transplant recipients with delayed graft function” will be presented during the ASTS poster session on
“Our research suggests that measuring dd-cfDNA via AlloSure may help identify the subset of DGF patients at risk early on, and allow more timely and effective interventions,” commented
“We are excited to partner with the
Additional information and resources on
For more information, please visit: www.CareDx.com.
Integrated Corporate Relations, Inc.
Source: CareDx, Inc.